Management of the Most Common Functional Gastrointestinal Disorders in Infancy: The Middle East Expert Consensus
- PMID: 34316467
- PMCID: PMC8279821
- DOI: 10.5223/pghn.2021.24.4.325
Management of the Most Common Functional Gastrointestinal Disorders in Infancy: The Middle East Expert Consensus
Abstract
The occurrence of functional gastrointestinal disorders (FGIDs) is a formidable challenge for infants, parents, and healthcare professionals. Although data from the Middle East are scarce, experts consider FGIDs a prevalent condition in everyday clinical practice. The new Rome IV criteria revisited the definitions from a clinical perspective to provide a practical and consistent diagnostic protocol for FGIDs. However, the treatment practices for functional disorders vary considerably among Middle Eastern countries, often resulting in mismanagement with unnecessary investigations and treatments. In addition, the role of various treatment modalities, including probiotics such as Lactobacillus reuteri DSM 17938, in FGIDs requires further discussion and evaluation. During a consensus meeting, a locally relevant approach for treating common FGIDs such as infant regurgitation, infant colic, and functional constipation was discussed and approved by regional experts. The participants suggested a simplified treatment plan and protocol for general pediatricians and other primary care physicians managing FGIDs. This easy-to-follow standardized protocol will help streamline the initial management of this complex disorder in the Middle East region and even globally.
Keywords: Colic; Constipation; Gastrointestinal diseases; Infant; Laryngopharyngeal reflux; Middle East; Probiotics.
Copyright © 2021 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition.
Conflict of interest statement
Conflict of Interest: Flavia Indrio serves as a Speaker for BioGaia, Nestlé Nutrition Institute and Danone. Axel Enninger serves as a speaker, member of advisory board Nestlé Nutrition Institute, Speaker, member of advisory board Milupa/Danone, Speaker: infectopharm, abbvie, Nutricia and Author: Thieme, infectopharm. None of the other authors have a conflict of interest.
Figures


References
-
- Benninga MA, Nurko S, Faure C, Hyman PE, St James Roberts I, Schechter NL. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2016;150:1443–55.e2. - PubMed
-
- Thompson WG. The road to Rome. Gastroenterology. 2006;130:1552–1556. - PubMed
-
- Iacono G, Merolla R, D'Amico D, Bonci E, Cavataio F, Di Prima L, et al. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005;37:432–438. - PubMed
-
- Zwiener R, Robin S, Keller C, Hyman PE, Nurko S, Saps M, et al. Prevalence of functional gastrointestinal disorders in infants and toddlers according to the Rome IV criteria. Gastroenterology. 2017;152:S649.